Many Options, Many Updates to NCCN Guidelines in Multiple Myeloma
Many Options, Many Updates to NCCN Guidelines in Multiple Myeloma Although the combination of bortezomib, lenalidomide, and dexamethasone remains the foundation the standard initial therapy for patients newly diagnosed with multiple myeloma (MM), the options for what to do next—including the timing of a stem cell transplant—have proliferated, and that is reflected in updates to […]
Read More